Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.13.11.52 extracted from

  • Corm, S.; Berthon, C.; Imbenotte, M.; Biggio, V.; Lhermitte, M.; Dupont, C.; Briche, I.; Quesnel, B.
    Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients sera by HPLC and is inducible by IFN-gamma (2009), Leuk. Res., 33, 490-494.
    View publication on PubMed

Application

Application Comment Organism
medicine in patients with acute myeloid leukemia, activity of indoleamine 2,3-dioxygenase can be monitored by measuring its metabolites in sera, and appears correlated with outcome. Monitoring indoleamine 2,3-dioxygenase activity provides a useful tool for future clinical trials of IDO inhibitors in acute myeloid leukemia Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
myeloid leukemia cell
-
Homo sapiens
-